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The mam characteristic hanges observed in Alzhetmer’s disease (AD) are the presence of neurofibrillary tangles and the deposrtion of amyloid 
A4 peptides. The most abundant amyloid A4 peptide species in AD (which we tentatively named A4’) is composed of 39 amino acids, which IS 
devoid of the 3 N-terminal amino acids, Asp-Ala-Glu, of the originally reported A4 peptide. We synthesized a model peptide substrate, Suc-Ala- 
Glu-methylcoumarinamide (MCA), to identify the proteinase that splits the A4’ peptide. DEAE-cellulose column chromatography of rat liver and 
porcine brain extracts howed that only one peak material digested the synthetic substrate at pH 8. The results for the final preparation indicate 
that the Sue-Ala-Glu-MCA-degrading enzyme is a high-molecular-mass proteinase, with a molecular mass of above 500 000, and is composed of 
several low-molecular-mass ubunits. These results suggest that a non-lysosomal multicatalytic proteinase (we named this enzyme ingensin (ingens = 
large in Latin), Ishiura, S. et al. (1985) FEBS Lett. 189, 119-123) catalyzes the above reaction. Antiserum against he purified multicatalytic protein- 
ase. ingensin, crossreacted with the purified Sue-Ala-Glu-MCA-degrading proteinase. It is likely that ingensin shows a similar action toward amyl- 
oid precursor protein (APP) in vivo. 
Multicatalytic proteinase; Amyloid A4; Proteolysis; Alzheimer’s disease, A4 peptide; Amyloid precursor protein; (Rat liver) 
1. INTRODUCTION 
Alzheimer’s disease (AD) is characterized by the 
deposition of amyloid in the brain, especially in senile 
plaques and neurofibrillary tangles [l-3]. Amyloid is 
thought to arise from abnormal cleavage of various 
proteins into self-aggregating fragments. The major 
component of AD amyloid is a 4.2 kDa polypeptide, 
referred to as the A4 or P-protein [4], corresponding to 
a membrane-spanning domain of a putative amyloid 
precursor protein (APP) whose amino acid sequence 
was deduced from the cDNA sequence. 
The APP gene produces at least 3 mRNAs, APP695, 
APP751 and APP770, the last two containing a se- 
quence highly homologous to that of Kunitz-type pro- 
teinase inhibitors [5-71. All these mRNAs encode the 
A4 peptide. A4 at positions 597-638 of the initially 
identified APP695 is a hydrophobic protein and the C- 
terminal half of the A4 is buried in the membrane (see 
fig. 1). The major peptide species in the amyloid plaque 
core in AD is peptide A4’, which corresponds to 
Phe60e--Ala638 (which comprises 64% of the total 
A4-related polypeptide) and an A4 peptide (12%) [8]. 
A4’ is found in larger amounts in neurofibrillary 
tangles than A4. A4’ is also a major material deposited 
in the brain of Down syndrome cases [9]. 
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On the basis of this structure, it has been suggested 
that the N-terminal portion of the A4 peptide is first 
cleaved off from the APP protein, and then the C- 
terminal end of A4 is cut off by another proteinase at 
the membrane to release the A4 or A4’ peptide. To 
determine the initial cleaving enzyme for A4 produc- 
tion, we synthesized a fluorogenic peptide substrate 
with a cleavage point. Since the amount of A4’ in AD 
is greater than that of A4, i.e. a Glu-Phe bond is more 
easily cleaved in vivo than a Lys-Met bond (see fig.l), 
N-terminus-blocked Ala-Glu-methylcoumarinamide 
(MCA) was selected to demonstrate the usefulness of 
synthetic substrates for characterization of the 
A4’-producing enzyme. In addition, we investigated 
the presence of Met-endopeptidase to identify another 
A6splitting activity. 
2. MATERIALS AND METHODS 
2.1. h4aterrals 
The peptide substrates, Sue-Ala-Glu-MCA and Suc-Leu-Met- 
MCA, were synthesized by Peptide Res. Inc., Osaka. Suc-Leu-Leu- 
Val-Tyr-MCA and microbial protease inhibitors were purchased 
from the same company. Aprotinin was obtained from Sigma. 
The multicatalytic proteinase, ingensin, was purified from rat liver 
according to the method previously reported [lo-141. Antibodies 
against he enzyme were raised in rabbits. Characterization of the en- 
zyme and the antibody was reported elsewhere [151. 
2.2. Assay method 
Standard assay mixtures comprised 50 mM Tris-HCI buffer, pH 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 388 
Volume 257, number 2 FEBS LETTERS November 1989 
Table 1 
Sue-Ala-Glu-MCA-degrading activity in the various organs of rat 
Organ Liberated AMC (nmol/mg per h) 











0.061 4 40 0.56 
0.061 1.44 0.44 
0.056 6.37 0 33 
0 028 2.03 0 52 
0.038 3.21 0 39 
0.094 4.27 0.56 
0.294 41.3 1 37 
0.327 41.7 3.65 
0.320 3.67 18.6 
0.168 4.25 I.94 
0.010 0.08 0.01 
7.0, containing 0.1 mM substrate and proteinase, in a totai volume 
of 0.1 ml. Incubations were performed for 30 min at 37°C. The 
cleavage product, aminomethyicoumarin (AMC), was analyzed, after 
stopping the reaction with 5% SDS, with a Hitachi F-3000 
fluorescence spectrophotometer. Methionine endopeptidase activity 
was determined at pH 8.0 with Sue-Leu-Met-MCA as a substrate. 
The analogue was first synthesized for cathepsins B&L [16], but a 
preliminary experiment showed that lysosomal cysteine proteinases 
do not digest it at slightly alkahne pH in the absence of an SH com- 
pound (data not shown). 
2.3. Extraction of tissue 
All operations were performed at 0-4°C. Fresh rat liver tissue 
(120 g) was suspended in 5 vols of 5 mM phosphate buffer, pH 7.0 
(KPB), and then lysed with a Waring blender. The homogenate was 
centrifuged at 10000 x g for 10 min and then ammonium sulfate was 
added (fmal, 30%) to remove mit~hondrial contamination. From 
the clear supernatant, proteins were precipitated by the addition of 
ammonium sulfate to 65% saturation. The resultant precipitate, 
which contained more than 95% of the cytosolic proteins, was 
dissolved in KPB and then dialyzed overnight against the same solu- 
tion. Further purification was achieved at neutral pH by 
chromatographies on DEAE-cellulose (O-O.5 M NaCI gradient) and 
hydroxyapatite (5-300 mM phosphate gradient), HPLC gel filtration 
(TSK G3000 SW) and finally chromatography on heparin-Sepharose 
(0- 1 M NaCl gradient). Fractions containing Suc-Ala-Glu-MCA- 
degrading activity were identified on the basis of cleavage of Suc- 
Leu-Leu-Val-Tyr-MCA as well as Western blot analysis. 
2.4. Gel eiectropkoresis and Western blotting 
Polypeptides were resolved in 12% polyacrylamide mini-stab gels 
and stained with Coomassie blue. For Western blotting, polypeptides 
were electrotransferred to nitrocellulose membranes at 150 mA for 
1 h and then the membranes were blocked with 5% non-fat milk. In- 
cubation with primary antisera was performed at room temperature 
for 1 h and detection was performed with an ABC kit 1171. 
3. RESULTS 
3.1. Distribution of the Sue-Ala-Glu-MCA-degrading 
enzyme in rat tissues 
Sue-Ala-Glu-MCA was used for investigation of the 
distribution of the putative A4-splitting enzyme in rat 
tissues. The activities of thiol cathepsins (substrate: Z- 
Phe-Arg-MCA) and the cytosolic multicatalytic pro- 
teinase, ingensin (substrate: Suc-Leu-Leu-Val-Tyr- 
MCA), were also checked for comparison. The results 
are summarized in table 1. Of the tissues tested, kidney, 
small intestine and liver showed the highest activity, 
followed by testis and lung. The hydrolytic activities 
toward Sue-Ala-Glu-MCA and Sue-Leu-Met-MCA at 
alkaline pH were roughly parallel in the rat tissues 
studied (data not shown). A similar tendency was 
observed in the case of thiol cathepsins B&L, but very 
high hydrolyzing activity toward Z-Phe-Arg-MCA at 
acidic pH was found in liver and kidney, but not in 
small intestine. On the other hand, hydrolyzing activity 
toward Sue-Leu-Leu-Val-Tyr-MCA, which is the 
specific substrate of the multicatalytic proteinase or 
ATP-dependent protease, is high in small intestine, 
followed by kidney and liver. A preliminary experiment 
showed that the high activity in the small intestine was 
due to chymase present in mast cells of the small in- 
testine. More than 95% of each activity was recovered 
in the supernatant from the whole homogenate on 
homogenization and sonication. Thus, Suc-Ala-Glu- 
MCA-degrading activity was shown to be widely 
distributed in rat tissues. In addition, Suc-Ala-Glu- 
MCA-degrading activity was detected in a small 
amount in the serum (table 1). 
Recent results of Weidemann et al. [18] showed that 
APP expressed in the cell surface (130 kDa) was quick- 
ly secreted in a C-terminal truncated form (112 kDa), 
suggesting that some serum enzyme cleaves the ex- 
tracellular domain of APP to release the N-terminal 
portion of the precursor. The residual low-molecular- 
mass membrane-associated form of APP should con- 
tribute to the A4 amyloid formation. Although the Ala- 
Glu sequence is located in the extracellular domain in 
putative membrane-associated forms, we decided to 
purify the Sue-Ala-Glu-MCA-degrading enzyme from 
rat liver. 
3.2. DEAE-cellulose column chromatography 
Fig. 1 shows the elution profile of the rat liver extract 
together with that of porcine brain on a DEAE- 
cellulose column. All of the activity was bound to the 
resin and was eluted at 0.25 M NaCl as a single peak. 
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Fig. 1. Amino acid sequence of the amyloid A4 peptide. The amino 
acid sequence of the A4 polypeptide, which is composed of 42 amino 
acids, is denoted by arrows. The N-terminal Asp of the A4 
polypeptide is Asp597 of the predicted APP695. The double 
underline indicates a probable membrane-spanning sequence of the 
A4 polypeptide reported by Kang et al. [4]. The most abundant 
species, A4’, begins at Phe600 of APP. The model peptide sequence 
used in the search for the A4’splitting enzyme is indicated by a thick 
underline. 
The results indicate that the activity found in the crude 
extract was due to a single enzyme. Subsequent 
chromatographies confirmed this. We assayed these 
fractions using several fluorogenic substrates, such as 
Z-Phe-Arg-MCA, Sue-Leu-Leu-Val-Tyr-MCA, Suc- 
Leu-Met-MCA, Sue-Gly-Pro-Leu-Gly-Pro-MCA, Arg- 
MCA and Leu-MCA. We found that the elution pro- 
files of Sue-Leu-Leu-Val-Tyr-MCA (pH 9) and Suc- 
Leu-Met-MCA (pH 8) coincided with those of neutral 
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Fig.2. DEAE-cellulose column chromatography of tissue extracts. 
80 g of rat liver (a) or porcine brain (b) was homogenized with 5 mM 
phosphate buffer, pH 7, and the supernatant was applied to a 200 ml 
DEAE-cellulose column. Proteins were eluted with a linear NaCl 
gradient (O-O.5 M, total, 1600 ml) and 20-ml fractions were 
collected. Sue-Ala-Glu-MCA (0) and Sue-Leu-Leu-Val-Tyr-MCA 
(0) degrading activities were determined as described under section 
2. FU, fluorescence unit which liberates nanomoles of AMC in our 
Elutlon time ( mln 1 
Fig.4. HPLC gel filtration. The two active peak materials were 
independently concentrated with ammonium sulfate and then applied 
to a HPLC gel filtration system (TSK G3OOOSW, 7.5 x 600 mm). The 
enzyme was eluted at 1 ml/min with 0.1 M phosphate buffer, pH 7.0. 
(a) Hydroxyapatite F.12-15 (corresponds to ingensin A [12]). (b) 
standard assay system with 20 I of enzyme sample. Hydroxyapatite F.35-45 (corresponds to ingensin B [12]). 
Frwtlon number 
Fig.3. Hydroxyapatite column chromatography of the Suc-Ala-Glu- 
MCA-degrading enzyme. The active fractions of the rat liver extract 
from a DEAE-column were dialyzed and then applied to a 20-ml 
hydroxyapatite column. A linear phosphate gradient (5-300 mM, 
total, 400 ml) was employed and 5 ml fractions were collected. 
3.3. Hydroxyapatite chromatography and gel filtration 
The active fractions from rat liver were collected and 
applied to a hydroxyapatite column (20 ml) 
equilibrated with 5 mM phosphate buffer, pH 7. A 
linear gradient (5-300 mM) was applied and the frac- 
tions collected (6 ml) were assayed for enzyme activity. 
Two peaks of activity were detected (fig.3) and these 
SOOk 3OOk 154k 43k a 
15 20 b 
b 4 
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peak materials degraded Sue-Leu-Leu-V~-Tyr-MCA~ 
which corresponded to the previously reported two 
isoenzymes of the multicatalytic proteinase, ingensins a 
and b. Subsequent chromatography of these active 
fractions on an HPLC column (TSK G3OOOSW, 7.5 X 
600 mm) indicated that both enzymes had a molecular 
mass of above 5~~ (fig.4). They still gave single 
peaks. The results exclude the possibility that other 
proteinases uch as chymase are copurified with this en- 
zyme on DEAE-cellulose and hydroxyapatite. 
The purified enzyme hydrolyzed not only Suc-Ala- 
Glu-MCA but also other substrates (table 2). It cleaved 
Table 2 
Synthetic substrate hydrolysis by the purified proteinase 




































Fig.5 Western blot analysis of the Sue-Ala-Glu-MCA degrading 
enzyme. Purified enzyme (5 ag) was subjected to 12% SDS 
potyacrylamide gel and then transferred to a nitrocellulose sheet. 
Lane a, anti-rat liver ingensin antiserum; lane b, preimmune serum. 
Immunoreactive components of molecular masses of 25-30 kDa are 
present in lane a, but not in lane b. Non-specific 62 kDa and 55 kDa 
bands are observed in both lanes. 
Sue-Leu-Leu-Val-Tyr-MCA and Boc-Leu-Arg-Arg- 
MCA most rapidly. From the substrate specificity and 
subunit composition (fig.5), it is likely that this enzyme 
is closely related to the multicatalytic proteinase, ingen- 
sin [19]. 
To determine whether or not the purified enzyme was 
identical to the multicatal~ic proteinase, Western blot 
analysis was performed (fig.5). Anti-rat liver ingensin 
antibody crossreacted with the Suc-Ala-Glu-MCA- 
degrading enzyme. These findings indicate that the 
cytosolic multicatalytic proteinase is one of the can- 
didates for the amyloid A4 splitting enzyme. 
4. DISCUSSION 
We do not known what the APP or A4 do. The 
results of immunocytochemical ocalization suggest 
that APP is located in neurons and skeletal muscle 1201. 
This and the proteoglycan nature of APP [Zl) sug- 
gested that APP is involved in cell-cell interaction. The 
recent finding that one of the predicted precursors, 
APP770, codes the Kunitz-type protease inhibitor also 
led to the proposal of the importance of a proteinase in 
amyloid formation. But no correlation of the expres- 
sion of the inhibitor-containing APP with A4 deposi- 
tion in AD was observed [22] and the exact role of the 
protease inhibitor remains unknown. In addition, the 
fact that in vitro-expressed APP lost its N-terminal ex- 
tracellular sequence after l-2 h, which resulted in a 
membrane-spanning, A4-containing peptide (17-18 
kDa), seemed to indicate a role of the protease inhibitor 
domain in A4 formation [ 181. This selective proteolytic 
release of the extracellular domain from an integrated 
membrane protein was also observed in several secre- 
tion processes, such as in the case of the IgA receptor 
[23]. It is important to determine whether or not the re- 
maining peptide has the same N-terminus as the A4 
peptide. But this is unlikely because A4 begins from 
position 597-695 of APP. The report of Weidemann 
suggests that APP was initially cleaved at the extracel- 
Iular domain just after membrane insertion, resulting in 
a 17-18 kDa fragment. Then, the A4-splitting enzyme 
cuts the latter and produces the A4 peptide afterwards. 
Our finding that a specific intracellular proteinase 
cleaves Sue-Ala-Glu-MCA indicates clearly that the 
A4-cleaving enzyme is derived from cellular parts after 
damage to the membrane. The tendency that an in 
vitro-expressed fragment beginning with the A4 se- 
quence does aggregate aIso suggests the involvement of 
the intracellular proteinase in A4 formation as a conse- 
quence of primary or secondary membrane damage. 
Two interesting results were obtained in this experi- 
ment. One is that the multicatal~ic proteinase cleaved 
both Met-X and Ala-Glu-X bonds. This easily explains 
the creation of several A4 species with different N- 
termini. The other is the possible involvement of the 
multicatalytic proteinase in amyloid formation. Our re- 
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cent finding that this enzyme is the same as ATP- 
dependent proteinase [ 15,241 clearly suggests the im- 
portance of this proteinase in cellular processes. Once 
abnormal proteins are synthesized, the proteins are 
degraded in an ATP-dependent manner. Hershko and 
Ciechanover demonstrated that ubiquitin is first attach- 
ed to abnormal proteins [25]. This process requires 
ATP. The ubiquitinated substrate is subsequently 
degraded by the proteinase, also in an ATP-dependent 
manner. Independently, it was demonstrated that a 
peptide hydrolysis in K562 cells is stimulated by ATP 
[24]. This is due to a multicatalytic proteinase, ingen- 
sin, which is stabilized at 37°C by ATP. If this enzyme 
recognizes abnormal proteins from the conjugated ubi- 
quitin or through an unknown mechanism, it is proper 
to postulate that ingensin digests abnormal APP. The 
frequent observation of ubiquitinated proteins in 
paired helical filaments in AD suggests the above 
possibility [27]. We are now trying to purify APP to 
determine whether the purified multicatalytic pro- 
teinase releases A4 peptide or induces aggregation. 
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